Safety and Efficacy of CAR-T Cell Therapy for Relapsed/refractory Neuroblastoma and Desmoplastic Small Round Cell Tumors: a Single-arm, Open-label Trial.

Clinical trial NCT06836505 · RECRUITING

Trial details

NCT number: NCT06836505
Sponsor: Sun Yat-Sen University Cancer Center
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Neuroblastoma (NB)Desmoplastic Small Round Cell Tumor (DSRCT)

Start date: 2024-12-12
Primary completion: 2027-12-12
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.